AFT narrows 1H loss as profit margin rises

Jenny Ruth
Wed, 21 Nov 2018

By Jenny Ruth Nov. 22 (BusinessDesk) - AFT Pharmaceuticals narrowed its losses in the latest first half year and says it’s on track to return to profitability The Maxigesic painkiller manufacturer’s net loss for the six months ended September eased to $4.2 million from $6.9 million in the same six months last year. It says the loss at the operating level – and before finance and other costs – was $109,000. Net finance costs rose to $2.5 million compared with $1.6 million in the previous first half as interest-bearing liabilities jum...

Unlock all stories
free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
Comprehensive business and markets coverage
News vie email, web and Apple/Android apps

Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Find out more

Subscribe now

Name

E-Mail Address

Password

Confirm Password

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Cardholder's Name

Card

You will be charged in 10 days unless you cancel beforehand. We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service {{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Or Subscribe with Google

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Technology

The Bose QC45 are simply great headphones

Henry Burrell | Sat, 04 Dec 2021

They’re feature-light compared to some rivals, but top-end noise cancellation and supreme comfort make these headphones a fine buy.

On the Money

On the Money: Greg Foran's golden words, Colin Neal, Chris Meehan, and more

Rebecca Stevenson | Sat, 04 Dec 2021

OTM this week: the value of a broken-down old shopkeeper, Colin Neal's next Move, Chris Meehan's real meaning of long-term, and more.

Opinion

Long live the broker, the broker is dead

Brian Gaynor | Sat, 04 Dec 2021

An increase in direct listings on the NZX is a welcome development, but they won’t gain any significant traction until brokers embrace them.

AFT narrows 1H loss as profit margin rises

Subscribe now

Or Subscribe with Google

Not convinced yet?

Your company has a subscription

Team